메뉴 건너뛰기




Volumn 7, Issue 7, 2014, Pages 708-716

Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; LICOFELONE; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN BAX; PROTEIN P21; PROTEIN P53; VASCULOTROPIN; LIPOXYGENASE; MESSENGER RNA; PYRROLE DERIVATIVE; UPK2 PROTEIN, MOUSE; UROPLAKIN 2; VIRUS T ANTIGEN;

EID: 84904311496     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0087     Document Type: Article
Times cited : (22)

References (45)
  • 1
    • 0003964363 scopus 로고    scopus 로고
    • American Cancer Society. Atlanta: American Cancer Society
    • American Cancer Society. Cancer facts & figures 2014. Atlanta: American Cancer Society; 2014.
    • (2014) Cancer Facts & Figures 2014
  • 4
    • 77950346282 scopus 로고    scopus 로고
    • Immunity, inflammation, and cancer
    • Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
    • (2010) Cell , vol.140 , pp. 883-899
    • Grivennikov, S.I.1    Greten, F.R.2    Karin, M.3
  • 5
    • 34247638102 scopus 로고    scopus 로고
    • Chronic inflammation and bladder cancer
    • DOI 10.1016/j.urolonc.2006.10.002, PII S107814390600233X, Inflammation in Bladder and Prostate Carcinogenesis
    • Michaud DS. Chronic inflammation and bladder cancer. Urol Oncol 2007;25:260-8. (Pubitemid 46670749)
    • (2007) Urologic Oncology: Seminars and Original Investigations , vol.25 , Issue.3 , pp. 260-268
    • Michaud, D.S.1
  • 6
    • 0043239039 scopus 로고    scopus 로고
    • Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder
    • DOI 10.1097/01.ju.0000080401.85145.ee
    • Shariat SF, Matsumoto K, Kim J, Ayala GE, Zhou JH, Jian W, et al. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. J Urol 2003;170:985-9. (Pubitemid 36999617)
    • (2003) Journal of Urology , vol.170 , Issue.3 , pp. 985-989
    • Shariat, S.F.1    Matsumoto, K.2    Kim, J.3    Ayala, G.E.4    Zhou, J.-H.5    Jian, W.6    Benedict, W.F.7    Lerner, S.P.8
  • 7
    • 0141988847 scopus 로고    scopus 로고
    • Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors
    • DOI 10.1097/01.ju.0000080296.54262.c8
    • Yoshimura R, Matsuyama M, Tsuchida K, Kawahito Y, Sano H, Nakatani T. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol 2003;170:1994-9. (Pubitemid 37254995)
    • (2003) Journal of Urology , vol.170 , Issue.5 , pp. 1994-1999
    • Yoshimura, R.1    Matsuyama, M.2    Tsuchida, K.3    Kawahito, Y.4    Sano, H.5    Nakatani, T.6
  • 8
    • 67549122884 scopus 로고    scopus 로고
    • Levels of prostaglandin E metabolite and leukotriene E4 are increased in the urine of smokers: Evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway
    • Duffield-Lillico AJ, Boyle JO, Zhou XK, Ghosh A, Butala GS, Subbaramaiah K, et al. Levels of prostaglandin E metabolite and leukotriene E4 are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res 2009;2:322-9.
    • (2009) Cancer Prev Res , vol.2 , pp. 322-329
    • Duffield-Lillico, A.J.1    Boyle, J.O.2    Zhou, X.K.3    Ghosh, A.4    Butala, G.S.5    Subbaramaiah, K.6
  • 9
    • 34249065795 scopus 로고    scopus 로고
    • Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines
    • Schroeder CP, Yang P, Newman RA, Lotan R. Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines. J Exp Ther Oncol 2007;6:183-92. (Pubitemid 46789718)
    • (2007) Journal of Experimental Therapeutics and Oncology , vol.6 , Issue.3 , pp. 183-192
    • Schroeder, C.P.1    Yang, P.2    Newman, R.A.3    Lotan, R.4
  • 10
    • 47849093031 scopus 로고    scopus 로고
    • Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2
    • Zhang Bo, Chang-Liang Wang, Wen-Hua Zhao, Ming Lv, Chun-Ying Wang, Wei-Xia Zhong, et al. Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2. World J Gastroenterol 2008;14:2494-500
    • (2008) World J Gastroenterol , vol.14 , pp. 2494-2500
    • Bo, Z.1    Wang, C.-L.2    Zhao, W.-H.3    Lv, M.4    Wang, C.-Y.5    Zhong, W.-X.6
  • 11
    • 0035584272 scopus 로고    scopus 로고
    • Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
    • DOI 10.1016/S0006-2952(01)00747-X, PII S000629520100747X
    • Fiorucci S, Meli R, Bucci M, Cirino G. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol 2001;62:1433-8. (Pubitemid 33145286)
    • (2001) Biochemical Pharmacology , vol.62 , Issue.11 , pp. 1433-1438
    • Fiorucci, S.1    Meli, R.2    Bucci, M.3    Cirino, G.4
  • 12
    • 0038328335 scopus 로고    scopus 로고
    • First clinical results of licofelone (ML3000), an inhibitor of COX-1, COX-2 and 5-LOX, for the treatment of osteoarthritis
    • Reginster JY, Bias P, Buchner A. First clinical results of licofelone (ML3000), an inhibitor of COX-1, COX-2 and 5-LOX, for the treatment of osteoarthritis. Ann Rheum Dis 2002;61:116-7.
    • (2002) Ann Rheum Dis , vol.61 , pp. 116-117
    • Reginster, J.Y.1    Bias, P.2    Buchner, A.3
  • 13
    • 1242342177 scopus 로고    scopus 로고
    • Licofelone - Clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis
    • Alvaro-Gracia JM. Licofelone-clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis. Rheumatology (Oxford) 2004;43 Suppl 1:i21-5. (Pubitemid 38219704)
    • (2004) Rheumatology , vol.43 , Issue.SUPPL. 1
    • Alvaro-Gracia, J.M.1
  • 15
    • 83055195235 scopus 로고    scopus 로고
    • Chemoprevention of colon and small intestinal tumorigenesis in APCMin/+ Mice by licofelone, a novel dual 5-LOX/COX inhibitor: Potential implications for human colon cancer prevention
    • Mohammed A, Janakiram NB, Li Q, Choi C-I, Zhang Y, Steele VE, et al. Chemoprevention of colon and small intestinal tumorigenesis in APCMin/+ Mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention. Cancer Prev Res 2011;4:2015-26.
    • (2011) Cancer Prev Res , vol.4 , pp. 2015-2026
    • Mohammed, A.1    Janakiram, N.B.2    Li, Q.3    Choi, C.-I.4    Zhang, Y.5    Steele, V.E.6
  • 16
    • 80051489648 scopus 로고    scopus 로고
    • Chemopreventive efficacy and mechanism of licofelone in a mouse lung tumor model via aspiration
    • Sharma S, Lee J, Zhou J, Steele VE. Chemopreventive efficacy and mechanism of licofelone in a mouse lung tumor model via aspiration. Cancer Prev Res 2011;4:1233-42.
    • (2011) Cancer Prev Res , vol.4 , pp. 1233-1242
    • Sharma, S.1    Lee, J.2    Zhou, J.3    Steele, V.E.4
  • 18
    • 0033565558 scopus 로고    scopus 로고
    • Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma
    • Zhang ZT, Pak J, Shapiro E, Sun TT, Wu XR. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res 1999;59:3512-7. (Pubitemid 29334516)
    • (1999) Cancer Research , vol.59 , Issue.14 , pp. 3512-3517
    • Zhang, Z.-T.1    Pak, J.2    Shapiro, E.3    Sun, T.-T.4    Wu, X.-R.5
  • 20
    • 84876561056 scopus 로고    scopus 로고
    • Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor
    • Hsu J-W, Hsu I, Xu D, Miyamoto H, Liang L, Wu X-R, et al. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. Am J Pathol 2013;182:1811-20.
    • (2013) Am J Pathol , vol.182 , pp. 1811-1820
    • Hsu, J.-W.1    Hsu, I.2    Xu, D.3    Miyamoto, H.4    Liang, L.5    Wu, X.-R.6
  • 21
    • 84890522483 scopus 로고    scopus 로고
    • Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model
    • Liu Z, Xu X, Li X, Liu S, Simoneau AR, He F, et al. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Cancer Prev Res 2013;6:1365-75.
    • (2013) Cancer Prev Res , vol.6 , pp. 1365-1375
    • Liu, Z.1    Xu, X.2    Li, X.3    Liu, S.4    Simoneau, A.R.5    He, F.6
  • 22
    • 84881077064 scopus 로고    scopus 로고
    • p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice
    • Madka V, Zhang Y, Li Q, Mohammed A, Sindhwani P, Lightfoot S, et al. p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice. Neoplasia 2013;15:966-74.
    • (2013) Neoplasia , vol.15 , pp. 966-974
    • Madka, V.1    Zhang, Y.2    Li, Q.3    Mohammed, A.4    Sindhwani, P.5    Lightfoot, S.6
  • 23
    • 0035710746 scopus 로고    scopus 로고
    • -ΔΔCT method
    • DOI 10.1006/meth.2001.1262
    • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001;25:402-8. (Pubitemid 34164012)
    • (2001) Methods , vol.25 , Issue.4 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 24
    • 84904364275 scopus 로고    scopus 로고
    • Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer
    • Zhu Z, Shen Z, Xu C. Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer. Mediators Inflamm 2012;1-11.
    • (2012) Mediators Inflamm , pp. 1-11
    • Zhu, Z.1    Shen, Z.2    Xu, C.3
  • 25
    • 33746405729 scopus 로고    scopus 로고
    • Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells
    • DOI 10.1111/j.1442-2042.2006.01485.x
    • Hayashi T, Nishiyama K, Shirahama T. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells. Int J Urol 2006;13:1086-91. (Pubitemid 44125681)
    • (2006) International Journal of Urology , vol.13 , Issue.8 , pp. 1086-1091
    • Hayashi, T.1    Nishiyama, K.2    Shirahama, T.3
  • 26
    • 4444225108 scopus 로고    scopus 로고
    • Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma
    • DOI 10.1016/j.colsurfb.2004.05.011, PII S0927776504001420
    • Li G, Yang T, Li L, Yan J, Zeng Y, Yu J, et al. Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma. Colloids Surfaces B Biointerfaces 2004;37:15-9. (Pubitemid 39164189)
    • (2004) Colloids and Surfaces B: Biointerfaces , vol.37 , Issue.1-2 , pp. 15-19
    • Li, G.1    Yang, T.2    Li, L.3    Yan, J.4    Zeng, Y.5    Yu, J.6    Zhang, Y.7
  • 27
    • 0032528189 scopus 로고    scopus 로고
    • Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N(4-hydroxybutyl) nitrosamine
    • Okajima E, Denda A, Ozono S, Takahama M, Akai H, Sasaki Y, et al. Chemo- preventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the develop- ment of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Res 1998;58:3028-31. (Pubitemid 28335083)
    • (1998) Cancer Research , vol.58 , Issue.14 , pp. 3028-3031
    • Okajima, E.1    Denda, A.2    Ozono, S.3    Takahama, M.4    Akai, H.5    Sasaki, Y.6    Kitayama, W.7    Wakabayashi, K.8    Konishi, Y.9
  • 28
    • 24144484811 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder
    • DOI 10.1007/s11255-004-4699-z
    • Wadhwa P, Goswami AK, Joshi K, Sharma SK: Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder. Int Urol Nephrol 2005;37:47-53. (Pubitemid 41236242)
    • (2005) International Urology and Nephrology , vol.37 , Issue.1 , pp. 47-53
    • Wadhwa, P.1    Goswami, A.K.2    Joshi, K.3    Sharma, S.K.4
  • 29
    • 0034667354 scopus 로고    scopus 로고
    • Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
    • Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, et al. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 2000;60:5599-602.
    • (2000) Cancer Res , vol.60 , pp. 5599-5602
    • Grubbs, C.J.1    Lubet, R.A.2    Koki, A.T.3    Leahy, K.M.4    Masferrer, J.L.5    Steele, V.E.6
  • 30
    • 0027144039 scopus 로고
    • Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model
    • DOI 10.1002/ijc.2910550622
    • Shibata MA, Hasegawa R, Shirai T, Takesada Y, Fukushima S. Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model. Int J Cancer 1993;55: 1011-7. (Pubitemid 24005349)
    • (1993) International Journal of Cancer , vol.55 , Issue.6 , pp. 1011-1017
    • Shibata, M.-A.1    Hasegawa, R.2    Shirai, T.3    Takesada, Y.4    Fukushima, S.5
  • 31
    • 0031059193 scopus 로고    scopus 로고
    • Effects of ibuprofen on the in vitro invasiveness of a human transitional cell carcinoma
    • Cook GP, Hampton JA. Effects of ibuprofen on the in vitro invasiveness of a human transitional cell carcinoma. Anticancer Res 1997;17:365-8. (Pubitemid 27116693)
    • (1997) Anticancer Research , vol.17 , Issue.1 A , pp. 365-368
    • Cook, G.P.1    Hampton, J.A.2
  • 32
    • 80053918672 scopus 로고    scopus 로고
    • A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer
    • Sabichi AL, Lee JJ, Grossman HB, Liu S, Richmond E, Czerniak BA, et al. A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res 2011;4:1580-9.
    • (2011) Cancer Prev Res , vol.4 , pp. 1580-1589
    • Sabichi, A.L.1    Lee, J.J.2    Grossman, H.B.3    Liu, S.4    Richmond, E.5    Czerniak, B.A.6
  • 33
    • 44049101630 scopus 로고    scopus 로고
    • Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: A role for thrombospondin-1
    • Johnson AM, O'Connell MJ, Miyamoto H, Huang J, Yao JL, Messing EM, et al. Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1. BMC Urol 2008;8:7.
    • (2008) BMC Urol , vol.8 , pp. 7
    • Johnson, A.M.1    O'Connell, M.J.2    Miyamoto, H.3    Huang, J.4    Yao, J.L.5    Messing, E.M.6
  • 34
    • 58849089319 scopus 로고    scopus 로고
    • Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes
    • Wang X, Colby JKL, Rengel RC, Fischer SM, Clinton SK, Klein RD. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes. Mol Carcinog 2009;48:1-13.
    • (2009) Mol Carcinog , vol.48 , pp. 1-13
    • Wang, X.1    Colby, J.K.L.2    Rengel, R.C.3    Fischer, S.M.4    Clinton, S.K.5    Klein, R.D.6
  • 35
    • 40549108939 scopus 로고    scopus 로고
    • Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade
    • DOI 10.1093/carcin/bgm265
    • Tavolari S, Bonafe M, Marini M, Ferreri C, Bartolini G, Brighenti E, et al. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. Carcinogenesis 2008;29:371-80. (Pubitemid 351359677)
    • (2008) Carcinogenesis , vol.29 , Issue.2 , pp. 371-380
    • Tavolari, S.1    Bonafe, M.2    Marini, M.3    Ferreri, C.4    Bartolini, G.5    Brighenti, E.6    Manara, S.7    Tomasi, V.8    Laufer, S.9    Guarnieri, T.10
  • 36
    • 84877070255 scopus 로고    scopus 로고
    • Multitargeted low-dose GLAD combination chemoprevention: A novel and promising approach to combat colon carcinogenesis
    • Mohammed A, Janakiram NB, Brewer M, Vedala K, Steele VE, Rao CV. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis. Neoplasia (Internet) 2013;15:481-90.
    • (2013) Neoplasia (Internet) , vol.15 , pp. 481-490
    • Mohammed, A.1    Janakiram, N.B.2    Brewer, M.3    Vedala, K.4    Steele, V.E.5    Rao, C.V.6
  • 40
    • 0141816863 scopus 로고    scopus 로고
    • Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53
    • Swamy MV, Herzog CR, Rao CV. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. Cancer Res 2003;63:5239-42. (Pubitemid 37139836)
    • (2003) Cancer Research , vol.63 , Issue.17 , pp. 5239-5242
    • Swamy, M.V.1    Herzog, C.R.2    Rao, C.V.3
  • 41
    • 84896115135 scopus 로고    scopus 로고
    • Anti-tumor activity of nonsteroidal anti-inflammatory drugs: Cyclooxygenase-independent targets
    • Liggett JL, Zhang X, Eling TE, Baek SJ. Anti-tumor activity of nonsteroidal anti-inflammatory drugs: cyclooxygenase-independent targets. Cancer Lett 2014;346:217-24.
    • (2014) Cancer Lett , vol.346 , pp. 217-224
    • Liggett, J.L.1    Zhang, X.2    Eling, T.E.3    Baek, S.J.4
  • 42
    • 67649969215 scopus 로고    scopus 로고
    • Expression analysis of VEGF-A and VEGF-B: Relationship with clinicopathological parameters in bladder cancer
    • Fauconnet S, Bernardini S, Lascombe I, Boiteux G, Clairotte A, Monnien F, et al. Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer. Oncol Rep 2009;21:1495-504.
    • (2009) Oncol Rep , vol.21 , pp. 1495-1504
    • Fauconnet, S.1    Bernardini, S.2    Lascombe, I.3    Boiteux, G.4    Clairotte, A.5    Monnien, F.6
  • 43
    • 84881348980 scopus 로고    scopus 로고
    • Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer
    • Kopparapu PK, Boorjian SA, Robinson BD, Downes M, Gudas LJ, Mongan NP, et al. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer. Anticancer Res 2013;33:2381-90.
    • (2013) Anticancer Res , vol.33 , pp. 2381-2390
    • Kopparapu, P.K.1    Boorjian, S.A.2    Robinson, B.D.3    Downes, M.4    Gudas, L.J.5    Mongan, N.P.6
  • 44
    • 30744476528 scopus 로고    scopus 로고
    • Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells
    • DOI 10.1016/j.cardiores.2005.09.019, PII S0008636305004931
    • Wu G, Luo J, Rana JS, Laham R, Sellke FW, Li J. Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res 2006;69:512-9. (Pubitemid 43098807)
    • (2006) Cardiovascular Research , vol.69 , Issue.2 , pp. 512-519
    • Wu, G.1    Luo, J.2    Rana, J.S.3    Laham, R.4    Sellke, F.W.5    Li, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.